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Abstract
Background: Many adults are living longer with health conditions in the United States. Understanding the
disability-adjusted life years (DALYs) for such health conditions may help to inform healthcare providers and their
patients, guide health interventions, reduce healthcare costs, improve quality of life, and increase longevity for
aging Americans. The purpose of this study was to determine the burden of 10 health conditions for a nationally-
representative sample of adults aged 50 years and older in the United States.
Methods: Data from the 1998–2014 waves of the Health and Retirement Study were analyzed. At each wave,
participants indicated if they were diagnosed with the following 10 conditions: cancer, chronic obstructive
pulmonary disease (COPD), congestive heart failure, diabetes, back pain, hypertension, a fractured hip, myocardial
infarction, rheumatism or arthritis, and a stroke. Years lived with a disability and years of life lost to premature
mortality were summed for calculating DALYs. Sample weights were utilized in the analyses to make the DALY
estimates nationally-representative. Results for the DALYs were presented in thousands.
Results: There were 30,101 participants included. Sex stratified DALY estimates ranged from 4092 (fractured hip)-to-
178,055 (hypertension) for men and 13,621 (fractured hip)-to-200,794 (hypertension) for women. The weighted
overall DALYs were: 17,660 for hip fractures, 62,630 for congestive heart failure, 64,710 for myocardial infarction,
90,337 for COPD, 93,996 for stroke, 142,012 for cancer, 117,534 for diabetes, 186,586 for back pain, 333,420 for
arthritis, and 378,849 for hypertension. In total, there were an estimated 1,487,734 years of healthy life lost from the
10 health conditions examined over the study period.
Conclusions: The burden of these health conditions accounted for over a million years of healthy life lost for middle-
aged and older Americans over the 16 year study period. Our results should be used to inform healthcare providers
and guide health interventions aiming to improve the health of middle-aged and older adults. Moreover, shifting
health policy and resources to match DALY trends may help to improve quality of life during aging and longevity.
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Background
Increased age is a hallmark risk factor for several health
conditions [1]. Although approximately 86% of older
adults in the United States are living with at least one
health condition [2], life expectancy in the United States
has generally continued to increase [3]. The advance-
ments in life expectancy have been attributed to many
factors including improvements in the prevention and
treatment of morbidity. Given that the older adult popu-
lation is projected to grow 112% by the year 2060 [4],
healthcare providers and policy makers need to continue
accommodating the emerging health demands of this
population for helping them live longer, and with more
quality years. For example, public health programs have
been developed for improving the wellbeing and longev-
ity of aging adults. Healthy People 2020 and 2030 in-
cludes initiatives to prevent morbidity, improve quality
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of care, and delay mortality for older adults in the
United States [5].
Disability-adjusted life years (DALYs) are used globally
to quantify the number of healthy years of life lost from
the presence of a disease, disability, or injury [6]. The bur-
den of chronic, non-fatal health loss and early mortality is
evaluated separately and compared across populations. In-
formation for DALYs in the United States and globally is
often provided in Global Burden of Disease studies [7].
Such information is used to inform healthcare providers
about the impact of a health condition and guide interven-
tions seeking to improve the health and life expectancy of
a given population [8]. Being that this time-based metric
measures the burden of a health condition in a population
and compares to a healthy population that reaches full life
expectancy, the specific burden of common health condi-
tions for middle-aged and older adults in the United States
has yet to be calculated.
More studies are needed for understanding how aging
is linked with disease [1]. Calculating the years lived with
a disease (YLDs) and years of life lost (YLLs) from pre-
mature mortality will provide insights into the burden of
common health conditions for the growing aging adult
population. This information can help to identify which
health conditions contribute most to the number of
healthy years of life lost for aging adults, thereby inform-
ing how healthcare providers and interventions prioritize
treatment and prevention efforts. Such prioritization will
help to guide health policy, and increase the quality of life
and longevity for aging adults. Therefore, the purpose of
this study was to determine the burden of 10 common
health conditions for a nationally-representative sample of
middle-aged and older adults in the United States.
Methods
Participants
Data from 37,495 participants in the 1998–2014 waves
of the Health and Retirement Study (HRS) were used.
Individual data files were joined to the cleaned and stan-
dardized RAND HRS dataset. The purpose of the HRS is
to understand the health and economic implications of
advancing age that can threaten or promote health and
wealth at individual- and population-levels [9]. Partici-
pants in the HRS have been re-interviewed biennially
since 1992. Further, the HRS includes surveys from over
23,000 households and has provided data for a
nationally-representative sample of Americans aged over
50 years since 1998 [10]. New cohorts of participants
have been added to the original HRS sample to preserve
national representation and participants are followed
longitudinally until death [10]. A multi-stage probability
design is used by the HRS, including geographical strati-
fication and oversampling of certain demographic
groups. Additional details for the HRS are described
elsewhere [11].
Written informed consent was acquired from all par-
ticipants before entering the study and protocols were
approved by the University of Michigan Behavioral Sci-
ences Committee Institutional Review Board. Participant
anonymity was ensured because data used in this sec-
ondary analysis contained no direct identifiers.
Health conditions
Participants self-reported their date of birth and sex. In-
terviewers asked participants questions related to their
physical health at each wave. Individuals who reported
having cancer, chronic obstructive pulmonary disease
(COPD), congestive heart failure, diabetes or high blood
sugar, back pain, high blood pressure or hypertension, a
fractured hip, a heart attack or myocardial infarction,
rheumatism or arthritis, or a stroke were included. The
date of interview for the wave a health condition was
first confirmed by participants was treated as a proxy for
the date of diagnosis. These health conditions were se-
lected by investigators because they were identified as
having a corresponding disability weight from the Global
Burden of Disease [12, 13]. Example interviewer ques-
tions for each health condition that were asked to partic-
ipants are listed in Additional file 1: Table S1.
Mortality
Date of death was obtained through linkage to the Na-
tional Death Index. The HRS also conducted an interview
with a surviving spouse, child, or other informant for each
decedent, successfully obtaining study exit information
[10].
Statistical analysis
Procedures from the World Health Organization for deter-
mining DALYs with an incidence-based calculation were
used [14]. Participants were first stratified by sex, then by
age categories (50–59 years, 60–69 years, 70–79 years, ≥80
years). The age at which a health condition occurred deter-
mined age categories for all participants.
YLDs were calculated by multiplying the number of inci-
dent cases for each health condition, corresponding disability
weight, and average duration of years lived with the health
condition until death, or truncation. For those who were still
alive or lost to follow-up (i.e., truncation), the average dur-
ation of years lived with the health condition was determined
using their estimated life expectancy at age of truncation
[15]. Disability weights for each health condition were from
the Global Burden of Disease (back pain = 0.020, cancer =
0.288, COPD= 0.019, congestive heart failure = 0.201, dia-
betes = 0.015, fractured hip = 0.058, hypertension = 0.246,
myocardial infarction = 0.439, rheumatism or arthritis
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=0.199, stroke = 0.266) [12, 13]. For each sex, YLDs were
summed across age categories to determine total YLDs.
YLLs were calculated by taking the product of the
number of deaths that occurred by the mean life expect-
ancy at age of death in years. The Period Life Table was
used to determine life expectancy at each age for men
and women [16]. The YLLs were summed across age
categories to determine total YLLs.
For men and women, YLDs and YLLs were added across
age categories to determine DALYs for each health condi-
tion. Then, the DALYs estimates were summed for calcu-
lating overall DALYs. Sample weights were utilized in the
analyses so DALYs were nationally-representative. The
YLLs, YLDs, and DALYs are reported in thousands. All
analyses were performed with SAS 9.4 software (SAS In-
stitute; Cary, NC).
Results
After exclusions (Fig. 1), there were 30,101 participants
included (n = 16,591 women, n = 13,510 men) from the
1998–2014 waves who reported having at least one of
the health conditions we examined. The non-weighted
and weighted descriptive characteristics of the partici-
pants are presented in Table 1. Overall, participants en-
tered the study at 63.3 ± 10.6 years of age. Of the 10,504
participants that died, the age at death was 79.6 ± 10.5
years. Table 2 provides person-level DALY estimates and
95% confidence intervals for each health outcome.
Figure 2 presents the weighted YLDs and YLLs for
each health condition stratified by sex. DALY estimates
for men were: 4092 for hip fractures, 28,707 for congest-
ive heart failure, 36,688 for myocardial infarction, 42,413
for COPD, 45,197 for stroke, 59,006 for diabetes, 68,237
for cancer, 86,392 for back pain, 144,991 for arthritis,
and 178,055 for hypertension. Likewise, DALY estimates
for women were: 13,621 for hip fractures, 27,855 for
myocardial infarction, 33,874 for congestive heart failure,
47,802 for COPD, 48,587 for stroke, 58,101 for diabetes,
73,529 for cancer, 99,736 for back pain, 188,177 for arth-
ritis, and 200,794 for hypertension. Of the ten health
Fig. 1 Flow Chart for Exclusions. †Exclusions occurred because races and ethnicities in the other category were stratified
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conditions examined herein, the number of DALYs for
diabetes and myocardial infarction were only higher in
men than women. In total, the 10 health conditions
accounted for an estimated 693,778 DALYs in men and
792,076 DALYs in women.
The weighted overall DALYs were: 17,660 for hip frac-
tures, 62,630 for congestive heart failure, 64,710 for
myocardial infarction, 90,337 for COPD, 93,996 for
stroke, 117,534 for diabetes, 142,012 for cancer, 186,586
for back pain, 333,420 for arthritis, and 378,849 for
hypertension. Detailed information for the weighted bur-
den of each health condition by sex and overall is pre-
sented in Table 3. As a whole, there were an estimated
347,274 YLDs, 1,140,457 YLLs, and 1,487,734 DALYs for
the 10 health conditions.
Discussion
The principal findings of this investigation revealed that
over 1-million years of healthy life were lost for
middle-aged and older Americans from the 10 health
conditions evaluated over the 16 year study period. Al-
though aging adults were impacted by each health con-
dition, hypertension accounted for the greatest burden;
whereas, hip fractures had the lowest number of DALYs.
These results were similar when evaluating the DALY
estimates for each of the health conditions by sex. Our
findings should be used to inform healthcare providers
and interventions seeking to prevent morbidity and ex-
tend life expectancy in aging adults. Using DALYs to
guide healthcare policy will also help to improve quality
of life during aging through continued evolutions of dis-
ease prevention and treatment.
The Global Burden of Disease studies have identified
hypertension as the leading risk factor by attributable
disease burden [17]. The prevalence of hypertension in-
creases with age, and is highest in older adults [18]. Of
the ten health conditions evaluated in this investigation,
hypertension had both the highest number of cases and
DALYs. Likewise, those with hypertension had a large
amount of YLDs, thereby indicating middle-aged and
older adults are living with this disease for long periods
of time after diagnosis. The large number of years lived
with hypertension can be attributed to the evolution and
adherence to hypertension medications [19, 20]. Like all
medications, persons considering usage of promising
hypertension medications should have discussions with a
healthcare provider, and other non-pharmacological
modes of treatment and prevention such as engaging in
healthy behaviors remains a critical factor for reducing
hypertension [18, 21]. Like hypertension, participants indi-
cating they had arthritis or rheumatism also lived with this
health condition for long periods of time after diagnosis as
demonstrated by the large number of YLDs. These results
align with another investigation that revealed rheumatoid
arthritis causes significant YLDs and high overall disease
burden [22]. It is projected that as smoking rates decline,
the number of healthy years of life lost from rheumatoid
arthritis will also decrease [22]. Future studies monitoring
DALYs for arthritis in middle-aged and older adults are
needed to confirm such projections and assess if arthritis
medications lower the burden of arthritis in aging adults.
Back pain is generally a prevalent health condition all
adults experience as they age and pain management is
often challenging [23]. The health implications of back
pain are also pronounced, as the Global Burden of Dis-
ease project demonstrated that back pain has a large
burden in the United States, and is relatively lower in
Asian countries [24, 25]. Although our results also sug-
gest the burden of back pain is high for middle-aged and
older adults in the United States, our findings for YLDs
are lower compared to those of other similar investiga-
tions [24, 25]. We believe that this result is attributed to
participants reporting back pain before entering the
HRS, as indicated by the large number of cases for those
aged 50–59 years. Cancer is also a leading cause of mor-
bidity and mortality in older adults [26]. The rise of can-
cer rates for the older adult population in the United
States is projected to increase, thereby posing challenges
to healthcare systems and cancer patients [27]. Our re-
sults show that the burden of cancer in aging adults is
high. Future investigations should continue monitoring
DALYs for cancer and specific cancer types in aging
adults to assess advancements in cancer treatment, care,
and prevention.
About 33% of adults aged at least 65 years in the
United States have diabetes and older adults with dia-
betes are at an elevated risk for mortality than those
without diabetes [28]. According to the Global Burden
of Disease, diabetes is a leading cause of DALYs in the
United States [29], and men are more frequently diag-
nosed with diabetes than women at younger ages [30].
Our findings indicate the number of diabetes cases were
Table 1 Non-Weighted and Weighted Descriptive Characteristics of the Participants
Overall
(n = 30,101)
Weighted Overall
(n = 114,610,740)
Women
(n = 16,591)
Weighted Women
(n = 59,183,770)
Men
(n = 13,510)
Weighted Men
(n = 55,426,970)
Age (years) 63.3 ± 10.6 60.9 ± 10.0 63.7 ± 11.1 61.8 ± 10.6 62.9 ± 10.0 60.1 ± 9.4
Age at Death (years) 79.6 ± 10.5 78.4 ± 11.0 81.2 ± 10.7 80.4 ± 10.8 77.9 ± 10.1 76.3 ± 10.9
Died (n (%)) 10,504 (34.9%) 31,954,223 (27.8%) 5553 (52.8%) 16,504,100 (27.9%) 4951 (16.4%) 15,450,123 (27.8%)
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Table 2 Person-Level Disability-Adjusted Life Year Means and 95% Confidence Intervals
Mean 95% Confidence Interval Mean 95% Confidence Interval Mean 95% Confidence Interval
Arthritis Back Pain Cancer
Males
50–59 Years 20.4 20.1, 20.8 20.6 20.2, 21.0 21.9 21.4, 22.5
60–69 Years 14.4 14.2, 14.6 13.4 13.2, 13.7 15.7 15.4, 16.0
70–79 Years 9.1 9.0, 9.2 8.4 8.2, 8.6 10.1 10.0, 10.3
≥80 Years 5.4 5.3, 5.4 4.5 4.4, 4.7 5.8 5.7, 6.0
Total 11.0 10.9, 11.2 10.5 10.2, 10.7 11.2 10.9, 11.4
Females
50–59 Years 23.0 22.7, 23.4 23.0 22.5, 23.5 24.8 24.2, 25.3
60–69 Years 16.1 15.9, 16.3 15.1 14.8, 15.4 17.5 17.2, 17.8
70–79 Years 9.9 9.8, 10.0 9.2 9.0, 9.4 11.1 10.9, 11.3
≥80 Years 5.8 5.7, 5.9 5.0 4.8, 5.1 6.5 6.4, 6.6
Total 11.0 10.8, 11.2 10.5 10.3, 10.7 12.5 12.2, 12.8
Overall
50–59 Years 21.8 21.6, 22.1 21.8 21.4, 22.1 23.5 23.1, 24.0
60–69 Years 15.2 15.1, 15.4 14.3 14.1, 14.5 16.6 16.4, 16.8
70–79 Years 9.5 9.5, 9.6 8.8 8.7, 9.0 10.6 10.5, 10.7
≥80 Years 5.7 5.6, 5.7 4.8 4.7, 4.9 6.2 6.1, 6.3
Total 11.0 10.9, 11.2 10.5 10.3, 10.7 11.8 11.6, 12.1
Chronic Obstructive Pulmonary Disease Congestive Heart Failure Diabetes
Males
50–59 Years 19.8 19.1, 20.4 21.7 20.9, 22.4 19.6 19.1, 20.1
60–69 Years 13.5 13.2, 13.9 15.4 15.0, 15.8 13.4 13.1, 13.7
70–79 Years 8.6 8.4, 8.8 9.8 9.6, 10.0 8.2 8.0, 8.4
≥80 Years 5.0 4.8, 5.1 5.2 5.1, 5.4 4.8 4.6, 5.0
Total 10.4 10.1, 10.7 10.4 10.0, 10.8 11.1 10.8, 11.3
Females
50–59 Years 21.9 21.2, 22.6 24.5 23.7, 25.3 22.0 21.5, 22.6
60–69 Years 15.6 15.2, 16.0 17.2 16.7, 17.7 15.0 14.7, 15.3
70–79 Years 9.6 9.3, 9.8 11.0 10.7, 11.3 9.1 8.9, 9.3
≥80 Years 5.3 5.1, 5.5 5.8 5.6, 5.9 5.3 5.1, 5.4
Total 11.5 11.2, 11.9 10.4 10.2, 10.7 11.9 11.6, 12.2
Overall
50–59 Years 20.9 20.4, 21.4 23.1 22.5, 23.7 20.8 20.4, 21.2
60–69 Years 14.6 14.3, 14.8 16.3 16.0, 16.6 14.2 14.0, 14.4
70–79 Years 9.1 8.9, 9.2 10.4 10.2, 10.6 8.6 8.5, 8.8
≥80 Years 5.1 5.0, 5.3 5.6 5.5, 5.7 5.1 4.9, 5.2
Total 11.0 10.7, 11.2 10.4 10.1, 10.6 11.5 11.3, 11.7
Fractured Hip Hypertension Myocardial Infarction
Males
50–59 Years – – 21.3 21.0, 21.6 22.4 21.8, 22.9
60–69 Years 13.6 12.6, 14.5 14.8 14.6, 15.0 16.5 16.2, 16.8
70–79 Years 9.0 8.4, 9.5 9.5 9.4, 9.6 10.9 10.7, 11.1
≥80 Years 4.8 4.5, 5.1 5.7 5.6, 5.8 6.5 6.4, 6.7
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higher in men than women, particularly at ages 50–59
and 60–69 years, which may explain why the burden of
diabetes was higher for men than women. While our
DALY estimates for diabetes were large, other countries
in the Global Burden of Disease, such as Mexico, may
have a higher burden from diabetes [25]. Similarly, our
results revealed the number myocardial infarction cases
and DALYs from this health condition were higher in
men compared to women. These results align with an-
other investigation that suggests the prevalence of myo-
cardial infarctions is higher in men than women [31].
Stroke is a leading cause of disability and death for
aging adults that is also responsible for billions of dollars
in healthcare costs [32]. Persons that sustain a stroke
have reduced mobility and are at an increased risk of ex-
periencing another stroke [33]. Therefore, it is not un-
usual that the burden of stroke has remained high in the
United States and globally [24, 25]. Our DALY results
for stroke also indicate many healthy years of life lost in
middle-aged and older adults. Although advancements
in COPD prevention and treatment have been made
[34], COPD remains a leading cause of death [35], and
the Global Burden of Disease suggests COPD has a tre-
mendous disease burden in the United States [29]. Given
that COPD is progressive, persons living with this dis-
ease have a large amount of health-related costs [36].
Table 2 Person-Level Disability-Adjusted Life Year Means and 95% Confidence Intervals (Continued)
Mean 95% Confidence Interval Mean 95% Confidence Interval Mean 95% Confidence Interval
Total 7.2 6.7, 7.7 11.9 11.8, 12.1 11.9 11.5, 12.2
Females
50–59 Years – – 23.8 23.5, 24.1 25.0 24.1, 25.8
60–69 Years 15.7 14.8, 16.6 16.6 16.4, 16.8 18.2 17.8, 18.7
70–79 Years 10.1 9.6, 10.5 10.3 10.2, 10.4 12.0 11.8, 12.3
≥80 Years 5.0 4.8, 5.2 6.1 6.0, 6.2 6.9 6.7, 7.1
Total 6.8 6.5, 7.1 11.7 11.5, 11.9 11.8 11.4, 12.3
Overall
50–59 Years – – 22.5 22.3, 22.7 23.5 22.9, 24.0
60–69 Years 15.0 14.3, 15.7 15.7 15.6, 15.8 17.1 16.9, 17.4
70–79 Years 9.7 9.3, 10.0 9.9 9.8, 10.0 11.4 11.2, 11.6
≥80 Years 5.0 4.8, 5.1 5.9 5.9, 6.0 6.7 6.6, 6.8
Total 6.9 6.7, 7.2 11.8 11.7, 12.0 11.8 11.6, 12.1
Stroke
Males
50–59 Years 21.5 20.8, 22.1
60–69 Years 15.8 15.4, 16.1
70–79 Years 9.7 9.5, 9.8
≥80 Years 5.5 5.3, 5.6
Total 10.6 10.3, 10.9
Females
50–59 Years 24.4 23.7, 25.1
60–69 Years 17.4 17.0, 17.8
70–79 Years 11.0 10.8, 11.2
≥80 Years 6.1 6.0, 6.2
Total 10.1 9.8, 10.4
Overall
50–59 Years 22.9 22.3, 23.4
60–69 Years 16.5 16.2, 16.8
70–79 Years 10.3 10.2, 10.5
≥80 Years 5.9 5.8, 6.0
Total 10.3 10.1, 10.5
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While our findings indicate that the burden of COPD is
already high, the burden of COPD is projected to in-
crease [37]. As smoking cessation remains important for
preventing and limiting the health effects of COPD, the
burden of DALYs should continue to be monitored for
helping to inform COPD treatments.
Heart failure is a worldwide health problem that is
linked to high morbidity, mortality, and costs of care
[38]. As the older adult population increases, the preva-
lence of heart diseases such as congestive heart failure
has also risen [39]. Our results indicating the high bur-
den of congestive heart failure are similar to those of
other investigations evaluating DALYs [40]. Although
hip fractures are common during aging, the incidence of
hip fractures and mortality rates associated with hip
fractures have declined in the United States [41, 42]. An-
other study evaluating DALYs for hip fractures deter-
mined that over 200,000 years of healthy life were lost
from hip fractures in older adults [43]. While the burden
of hip fractures was lowest of the ten health conditions
for this investigation, prevention and treatment for hip
fractures should remain a priority for aging adults.
Some limitations should be noted. Those who were
lost from follow-up or died may have had a health con-
dition that was not recorded before this event, thereby
creating underestimations for our results. Moreover, the
date of interview served as a proxy for diagnosis date,
thereby allowing our results to be further underesti-
mated. The use of an incidence-driven DALY calculation
allowed us to determine how the burden of specific
health conditions impacted middle-aged and older adults
longitudinally; however, we were unable to control for
multimorbiditiy in our disability weights. It is also pos-
sible that participants may have disputed their records
for having a diagnosis or were no longer living with a
health condition after initial diagnosis. Self-report biases
may have occurred for participant responses. The HRS
only includes adults aged 50 years and over; therefore,
some participants may have had health conditions at
younger ages before entering the study. Statistical tests
of inference were not used for making comparisons be-
tween DALY estimates because DALYs are often used as
a stand-alone statistic.
Likewise, our DALY estimates were influenced by
cases, and YLD does not confirm that quality of life was
compromised. Future investigations should examine the
impact of a health condition on YLD because a smaller
YLD may imply that a health condition exacerbates time
to death; whereas, a larger YLD may suggest treatment
and management of a health condition delays early mor-
tality (depending on age of diagnosis and other import-
ant factors). As such, social and policy concerns for
aging adults including living arrangements, finances,
completion of autonomous living and basic self-care
tasks, and care giving should be considered based on
disease and health status. Comparing our findings with
those of other burden of disease investigations performed
in the United States and globally will be helpful for mak-
ing comparisons across populations and diseases
[44]. Moreover, expanding parts of the DALY calculation
to other important health outcomes during aging and
examining prevalence-based DALYs will help to advance
our understanding of health burden.
Conclusions
The burden of the health conditions evaluated for this in-
vestigation accounted for over a million years of healthy
life lost for middle-aged and older Americans during the
study period. Overall, participants experienced different
levels of non-fatal health loss and early mortality for each
health condition. These results should be used to help im-
prove the efficiency and effectiveness of disease prevention
and treatment strategies for aging adults. Trends in
DALYs should continue to be monitored for middle-aged
Fig. 2 The Burden of the Health Outcomes for Middle-Aged and Older Adults Stratified by Sex. Note: Green Bars = Years of Life Lost; Yellow Bars
= Years Lived with Disease. COPD = Chronic Obstructive Pulmonary Disease; DALYs = Disability-Adjusted Life Years
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Table 3 Disability-Adjusted Life Years for Each Health Outcome
Cases Number Dead YLLs (in thousands) YLDs (in thousands) DALYs (in thousands)
Arthritis
Males
50–59 Years 13,140,604 1,767,444 33,628 19,243 52,871
60–69 Years 9,293,034 2,465,646 31,798 14,254 46,053
70–79 Years 5,768,620 3,415,221 26,344 8051 34,396
≥80 Years 2,600,532 2,069,681 9260 2411 11,671
Total 30,802,790 9,717,992 101,030 43,959 144,991
Females
50–59 Years 16,094,235 1,583,622 34,047 25,641 59,688
60–69 Years 11,064,877 2,422,174 35,011 18,417 53,428
70–79 Years 8,296,633 4,304,371 36,176 13,157 49,333
≥80 Years 5,291,347 4,199,135 20,000 5728 25,728
Total 40,747,092 12,509,302 125,234 62,943 188,177
Overall
50–59 Years 29,234,839 3351,066 68,226 44,842 113,068
60–69 Years 20,357,911 4,887,820 66,848 32,557 99,405
70–79 Years 14,065,253 7,719,592 62,446 21,085 83,532
≥80 Years 7,891,879 6,268,816 29,270 8145 37,415
Total 71,549,882 22,227,294 226,790 106,629 333,420
Back Pain
Males
50–59 Years 15,686,707 1,740,053 35,669 1980 37,648
60–69 Years 6,832,356 1,653,968 22,088 932 23,021
70–79 Years 4,396,870 2,113,526 17,575 530 18,105
≥80 Years 2,184,198 1,645,791 7424 194 7618
Total 29,100,131 7,153,338 82,756 3636 86,392
Females
50–59 Years 15,354,395 1,241,525 28,443 2126 30,569
60–69 Years 8,568,148 1,788,250 26,819 1221 28,040
70–79 Years 6,382,777 2,705,337 24,726 881 25,607
≥80 Years 4,351,801 3,076,734 15,084 436 15,520
Total 34,657,121 8,811,846 95,072 4664 99,736
Overall
50–59 Years 31,041,102 2,981,578 64,644 4104 68,747
60–69 Years 15,400,504 3,442,218 48,969 2151 51,120
70–79 Years 10,779,647 4,818,863 42,198 1400 43,598
≥80 Years 6,535,999 4,722,525 22,493 628 23,121
Total 63,757,252 15,965,184 178,304 8283 186,586
Cancer
Males
50–59 Years 2,522,588 636,050 12,994 3863 16,857
60–69 Years 3,755,041 1,213,733 17,078 6250 23,328
70–79 Years 3,472,371 1,731,529 14,875 5443 20,318
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Table 3 Disability-Adjusted Life Years for Each Health Outcome (Continued)
Cases Number Dead YLLs (in thousands) YLDs (in thousands) DALYs (in thousands)
≥80 Years 1,618,157 1,236,842 5880 1854 7734
Total 11,368,157 4,818,154 50,827 17,410 68,237
Females
50–59 Years 3,700,463 591,564 13,619 6663 20,282
60–69 Years 3,429,015 1,027,035 16,203 6220 22,423
70–79 Years 3,072,482 1,655,490 15,535 5413 20,948
≥80 Years 1,988,047 1385,791 7186 2690 9876
Total 12,190,007 4,659,880 52,543 20,986 73,529
Overall
50–59 Years 6,223,051 1,227,614 26,898 10,487 37,385
60–69 Years 7,184,056 2,240,768 33,349 12,469 45,818
70–79 Years 6544,853 3,387,019 30,372 10,862 41,234
≥80 Years 3,606,204 2,622,633 13,055 4520 17,575
Total 23,558,164 9,478,034 103,674 38,338 142,012
Chronic Obstructive Pulmonary Disease
Males
50–59 Years 2,580,113 632,447 12,445 316 12,762
60–69 Years 2,591,636 986,541 13,276 324 13,600
70–79 Years 2,108,494 1,366,288 11,661 208 11,869
≥80 Years 1,039,325 830,476 4116 67 4182
Total 8,319,568 3,815,752 41,498 915 42,413
Females
50–59 Years 3,470,551 624,008 13,626 478 14,104
60–69 Years 2,847,547 906,558 14,095 375 14,469
70–79 Years 2,563,061 1,422,684 13,507 298 13,805
≥80 Years 1,407,161 1,011,150 5312 112 5424
Total 10,288,320 3,964,400 46,540 1263 47,802
Overall
50–59 Years 6,050,664 1,256,455 26,209 792 27,001
60–69 Years 5,439,183 1,893,099 27,426 697 28,124
70–79 Years 4,671,555 2,788,972 25,102 501 25,604
≥80 Years 2,446,486 1,841,626 9430 178 9608
Total 18,607,888 7,780,152 88,167 2168 90,337
Congestive Heart Failure
Males
50–59 Years 901,813 309,556 6407 928 7335
60–69 Years 1,093,609 452,061 6563 1020 7584
70–79 Years 1,359,220 924,139 8239 1249 9487
≥80 Years 956,151 794,466 3742 559 4301
Total 4,310,793 2,480,222 24,951 3756 28,707
Females
50–59 Years 783,103 218,141 5114 880 5994
60–69 Years 1,004,064 434,919 7028 1083 8111
70–79 Years 1,449,735 979,321 9791 1535 11,325
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Table 3 Disability-Adjusted Life Years for Each Health Outcome (Continued)
Cases Number Dead YLLs (in thousands) YLDs (in thousands) DALYs (in thousands)
≥80 Years 1,716,177 1,411,609 7293 1151 8444
Total 4,953,079 3,043,990 29,226 4649 33,874
Overall
50–59 Years 1,684,916 527,697 11,634 1813 13,447
60–69 Years 2,097,673 886,980 13,590 2107 15,697
70–79 Years 2,808,955 1,903,460 17,972 2772 20,744
≥80 Years 2,672,328 2,206,075 11,033 1709 12,742
Total 9,263,872 5,524,212 54,229 8401 62,630
Diabetes
Males
50–59 Years 6,357,757 1,136,872 22,201 652 22,853
60–69 Years 5,109,121 1,327,408 17,770 535 18,305
70–79 Years 3,110,939 1,702,148 13,938 291 14,229
≥80 Years 1,111,108 743,942 3546 73 3619
Total 15,688,925 4,910,370 57,455 1551 59,006
Females
50–59 Years 5,545,897 856,217 18,801 635 19,436
60–69 Years 4,846,946 1,185,951 17,734 543 18,276
70–79 Years 3,287,663 1,603,639 14,515 340 14,855
≥80 Years 1,588,280 1,035,687 5430 104 5534
Total 15,268,786 4,681,494 56,480 1622 58,101
Overall
50–59 Years 11,903,654 1,993,089 41,352 1292 42,644
60–69 Years 9,956,067 2,513,359 35,588 1078 36,666
70–79 Years 6,398,602 3,305,787 28,432 629 29,061
≥80 Years 2,699,388 1,779,629 8986 177 9163
Total 30,957,711 9,591,864 114,358 3176 117,534
Fractured Hip
Males
50–59 Years 0 0 – – –
60–69 Years 146,403 41,458 554 39 593
70–79 Years 380,325 226,413 1969 118 2087
≥80 Years 441,705 287,456 1343 70 1412
Total 968,433 555,327 3866 227 4092
Females
50–59 Years 0 0 – – –
60–69 Years 324,722 115,798 1791 88 1879
70–79 Years 894,606 501,588 4931 267 5198
≥80 Years 1,814,079 1,272,571 6168 376 6544
Total 3,033,407 1,889,957 12,890 731 13,621
Overall
50–59 Years 0 0 – – –
60–69 Years 471,125 157,256 2324 127 2451
70–79 Years 1,274,931 728,001 6868 386 7254
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Table 3 Disability-Adjusted Life Years for Each Health Outcome (Continued)
Cases Number Dead YLLs (in thousands) YLDs (in thousands) DALYs (in thousands)
≥80 Years 2,255,784 1,560,027 7509 446 7955
Total 4,001,840 2,445,284 16,701 959 17,660
Hypertension
Males
50–59 Years 17,589,184 2,219,853 43,583 30,454 74,037
60–69 Years 10,044,721 2,652,896 34,384 18,925 53,310
70–79 Years 6,329,398 3,587,473 27,980 10,942 38,922
≥80 Years 2,551,064 1,933,743 8767 3018 11,786
Total 36,514,367 10,393,965 114,714 63,339 178,055
Females
50–59 Years 15,159,062 1,560,757 34,321 28,232 62,554
60–69 Years 10,942,927 2,570,377 37,670 21,718 59,388
70–79 Years 8,588,794 4,388,589 36,871 16,804 53,674
≥80 Years 5,024,558 3,838,927 18,314 6864 25,178
Total 39,715,341 12,358,650 127,176 73,618 200,794
Overall
50–59 Years 32,748,246 3,780,610 77,904 58,686 136,591
60–69 Years 20,987,648 5,223,273 72,054 40,643 112,698
70–79 Years 14,918,192 7,976,062 64,851 27,746 92,596
≥80 Years 7,575,622 5,772,670 27,081 9882 36,964
Total 76,229,708 22,752,615 241,890 136,957 378,849
Myocardial Infarction
Males
50–59 Years 1,477,509 311,855 6054 4451 10,505
60–69 Years 1,472,041 555,368 7866 3466 11,332
70–79 Years 1,322,100 781,906 6584 3304 9888
≥80 Years 844,074 721,969 3578 1385 4963
Total 5,115,724 2,371,098 24,082 12,606 36,688
Females
50–59 Years 648,934 147,456 3181 2242 5422
60–69 Years 850,883 350,042 5548 2080 7628
70–79 Years 1,021,117 656,615 6217 2686 8903
≥80 Years 999,380 803,335 4090 1811 5902
Total 3,520,314 1,957,448 19,036 8819 27,855
Overall
50–59 Years 2126,443 459,311 9333 6800 16,133
60–69 Years 2,322,924 905,410 13,392 5548 18,940
70–79 Years 2,343,217 1,438,521 12,783 5993 18,776
≥80 Years 1,843,454 1,525,304 7669 3193 10,861
Total 8,636,038 4,328,546 43,177 21,534 64,710
Stroke
Males
50–59 Years 1,566,132 450,841 8890 2850 11,739
60–69 Years 1,849,572 736,604 10,615 2581 13,195
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and older adults so that health-related policies and re-
sources match DALY trends, and for informing healthcare
providers so they can accommodate the health needs of
the growing aging population in the United States. En-
couraging healthcare providers to continue evolving pre-
vention, treatment, and early detection for disease, and
healthcare policy makers to invest in promising solutions
will help to reduce health-related costs, improve quality of
life, and extend life expectancy for the aging adults in the
United States.
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